Tholander B, Koliadi A, Botling J, Dahlstrand H, Von Heideman A, Ahlström H, Öberg K, Ullenhag GJ. Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma. ujms [Internet]. 2020Oct.10 [cited 2024Apr.25];125(4):325–329. Available from: https://ujms.net/index.php/ujms/article/view/5716